Dual-mode tracer could enable surgeons to see and ‘hear’ prostate cancer
A preclinical evaluation of a new “dual-mode” tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during surgery.